Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of LifeStance Health Group Inc (NASDAQ: LFST) closed at $5.63 in the last session, down -0.71% from day before closing price of $5.67. In other words, the price has decreased by -$0.71 from its previous closing price. On the day, 1.18 million shares were traded.
Ratios:
We take a closer look at LFST’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.30 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.38. For the most recent quarter (mrq), Quick Ratio is recorded 1.47 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, KeyBanc Capital Markets on April 08, 2025, initiated with a Overweight rating and assigned the stock a target price of $9.
On April 03, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $8.
Goldman Upgraded its Neutral to Buy on December 16, 2024, while the target price for the stock was maintained at $10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 09 ’25 when Bessler Robert sold 4,900 shares for $7.01 per share. The transaction valued at 34,349 led to the insider holds 1,421,990 shares of the business.
Bessler Robert sold 14 shares of LFST for $98 on Apr 08 ’25. The Director now owns 1,424,440 shares after completing the transaction at $7.00 per share. On Apr 09 ’25, another insider, Bessler Robert, who serves as the Director of the company, bought 4,900 shares for $7.01 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.71 while its Price-to-Book (P/B) ratio in mrq is 1.50.
Stock Price History:
Over the past 52 weeks, LFST has reached a high of $8.61, while it has fallen to a 52-week low of $4.64. The 50-Day Moving Average of the stock is -12.71%, while the 200-Day Moving Average is calculated to be -19.51%.
Shares Statistics:
A total of 388.83M shares are outstanding, with a floating share count of 117.17M. Insiders hold about 69.87% of the company’s shares, while institutions hold 36.30% stake in the company.
Earnings Estimates
A comprehensive evaluation of LifeStance Health Group Inc (LFST) is underway, with the input of 1.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.02, with high estimates of $0.02 and low estimates of $0.02.
Analysts are recommending an EPS of between $0.06 and $0.06 for the fiscal current year, implying an average EPS of $0.06. EPS for the following year is $0.09, with 1.0 analysts recommending between $0.09 and $0.09.
Revenue Estimates
According to 7 analysts, the current quarter’s revenue is expected to be $347.33M. It ranges from a high estimate of $352.5M to a low estimate of $339.75M. As of the current estimate, LifeStance Health Group Inc’s year-ago sales were $312.33MFor the next quarter, 7 analysts are estimating revenue of $359.12M. There is a high estimate of $365.9M for the next quarter, whereas the lowest estimate is $355.22M.
A total of 8 analysts have provided revenue estimates for LFST’s current fiscal year. The highest revenue estimate was $1.42B, while the lowest revenue estimate was $1.4B, resulting in an average revenue estimate of $1.41B. In the same quarter a year ago, actual revenue was $1.25BBased on 8 analysts’ estimates, the company’s revenue will be $1.61B in the next fiscal year. The high estimate is $1.64B and the low estimate is $1.57B.
